Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia
Mayumi Sugita(Cornell University), Mónica L. Guzmán(NewYork–Presbyterian Hospital)
Cited by 36
Related Papers
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2021|714
The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells
|Blood|2005|675
Crenolanib is a selective type I pan-FLT3 inhibitor
|Proceedings of the National Academy of Sciences|2014|211